Skip to main content

JKI 22 (Xeljanz XR 22 mg)

Generic Name: tofacitinib

Pill with imprint JKI 22 is Beige, Elliptical / Oval and has been identified as Xeljanz XR 22 mg. It is supplied by Pfizer Inc..

Xeljanz XR is used in the treatment of psoriatic arthritis; ulcerative colitis; rheumatoid arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz XR 22 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for JKI 22

Xeljanz XR

Generic Name
tofacitinib
Imprint
JKI 22
Strength
22 mg
Color
Beige
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antirheumatics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-0502

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.